Racial differences in outcomes for patients with metastatic breast cancer by disease subtype-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Racial differences in outcomes for patients with metastatic breast cancer by disease subtype

Published:2015-05-29 Issue:3 Volume:151 Page:697-707
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Vaz-Luis Ines,Lin Nancy U.,Keating Nancy L.,Barry William T.,Lii Huichuan,Winer Eric P.,Freedman Rachel A.

Funder

Fundação para a Ciência e a Tecnologia

Dana-Farber Cancer Institute Friends Award

CJL Foundation

Susan G. Komen for the Cure

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-015-3432-1.pdf

Reference44 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA 61(2):69–90. doi: 10.3322/caac.20107

2. Early Breast Cancer Trialists’ Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717

3. Miller KD, Sledge GW Jr (1999) The role of chemotherapy for metastatic breast cancer. Hematol/oncol clin N Am 13(2):415–434

4. Chia SK, Speers CH, D’Yachkova Y, Kang A, Malfair-Taylor S, Barnett J, Coldman A, Gelmon KA, O’Reilly SE, Olivotto IA (2007) The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer 110(5):973–979. doi: 10.1002/cncr.22867

5. Andre F, Slimane K, Bachelot T, Dunant A, Namer M, Barrelier A, Kabbaj O, Spano JP, Marsiglia H, Rouzier R, Delaloge S, Spielmann M (2004) Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol 22(16):3302–3308. doi: 10.1200/JCO.2004.08.095

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geographic and sociodemographic access to systemic anticancer therapies for secondary breast cancer: a systematic review;Systematic Reviews;2024-01-18

2. Prognostic implications of HER2NEU‐low in metastatic breast cancer;Cancer Medicine;2024-01

3. The impact of geographical and sociodemographic variation on access to Systemic Anti- Cancer Therapies for Secondary Breast Cancer: A systematic review;2022-10-18

4. Chemokine receptors differentially expressed by race category and molecular subtype in the breast cancer TCGA cohort;Scientific Reports;2022-06-26

5. A pharmacokinetic study to comparatively evaluate the bioequivalence and safety of a humanized recombinant monoclonal antibody targeting human epidermal growth factor receptor-2 with the reference Herceptin in healthy Chinese subjects;Investigational New Drugs;2022-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3